Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited

Nav

General Info

Email
Print

Geography

Argentina (ARG)

Austria (AUT)

Belarus (BLR)

Belgium (BEL)

Bosnia and Herzegovina (BIH)

Croatia (HRV)

Czechia (CZE)

Denmark (DNK)

Estonia (EST)

Finland (FIN)

France (FRA)

Georgia (GEO)

Germany (DEU)

Greece (GRC)

Hungary (HUN)

Iceland (ISL)

Ireland (IRL)

Israel (ISR)

Italy (ITA)

Netherlands (NLD)

Russian Federation (RUS)

Spain (ESP)

Sweden (SWE)

Switzerland (CHE)

Ukraine (UKR)

United Kingdom (GBR)

View all

Time period covered

01/1994 - 12/2001

Data type

Scientific literature

Keywords

Antiretroviral therapy, HIV and AIDS

Citation

Authors

Moore AL, Kirk O, Johnson AM, Katlama C, Blaxhult A, Dietrich M, Colebunders R, Chiesi A, Lungren JD, Phillips AN, EuroSIDA group

Journal

J Acquir Immune Defic Syndr

Volume

32

Issue

4

Pages

452-61

Publication year

2003

Suggested citation

Moore AL, Kirk O, Johnson AM, Katlama C, Blaxhult A, Dietrich M, Colebunders R, Chiesi A, Lungren JD, Phillips AN, EuroSIDA group. Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited. J Acquir Immune Defic Syndr. 2003; 32(4): 452-61.

GHDx Entry last modified on: Oct 24, 2024